Ep. 60 - Public opinions on Wegovy and other weight loss drugs
Manage episode 375124383 series 3502474
Contenuto fornito da Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights
…
continue reading
- COVID still matters, especially for those at risk
- The cost of weight loss drugs in the US compared to other countries
- The need for a free market economy in healthcare
- Public opinion on prescription weight loss drugs
- The potential impact of covering weight loss drugs under insurance
- COVID can still be severe for at-risk populations
- Vaccines can help prevent severe symptoms
- The US pays more for weight loss drugs compared to other countries
- The prevalence of obesity is high in the US
- The cost of covering weight loss drugs for all Americans would be significant
- Stay informed about the ongoing impact of COVID
- Consider the cost of weight loss drugs and explore alternative options
- Share your opinion on prescription weight loss drugs
- Advocate for healthcare policies that promote a free market economy
106 episodi